Patient preference was the predominant reason for declining trial entry , given by 47 ( 53 per cent ) of the 88 patients approached for QUEST A and 22 ( 61 per cent ) of the 36 approached for QUEST B. Both trials closed to recruitment in December 2012 , acknowledging the challenges of achieving satisfactory patient accrual .